Publication | Open Access

Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival

Epigenetic SilencingMedicineEpigenetic ChangeGynecologyPathologyCancer GenomicsCancer BiologyEndometrial CancersTumor MicroenvironmentTumor BiologyEndocrine-related CancerLarger Tumor Volume